Beo Santé

Smart health for a better life

Capital increase: warrants at €120/share.
If you want to invest in Beo Santé :

Objective: to accelerate marketing and develop new versions of the VATA application co-developed with the founders Physio R&D.

Strong collaboration between experts in new technologies and medical researchers


Physio R&D

Success factors

An experienced team for over 10 years

A consolidated partnership since 2016

Ongoing clinical trials

Market penetration through sales to laboratories

Our prices

Find out more